Hu Jiancheng
Cosmetics and medicines
Hospital
Singapore
Biography
Hu Jiancheng received his PhD from University of Colorado Denver in 2007 and then Post-doctoral training at Washington University in St. Louis and Howard Hughes Medical Institute. Since 2014, he has joined National Cancer Centre Singapore where he has served as the Principal Investigator at the Laboratory of Cancer Signaling. He has published more than 15 papers in international renowned journals. His research interests include: (1) the regulatory mechanism of RAF kinase and other oncogenic protein kinases under normal/pathological conditions; (2) molecular basis that underlie intrinsic and acquired resistance of kinase inhibitors in clinic treatment of cancers; (3) the development of novel kinase inhibitors.
Research Interest
Surgery
